Back
Arbutus Biopharma Vs. Vista Energy SAB de CV Industry Stock Comparison
Sell
29
ABUS
Arbutus Biopharma
Last Price:
$3.36
Seasonality Move:
4.69%
Sell
50
VIST
Vista Energy SAB de CV
Last Price:
$49.40
Seasonality Move:
17.72%
Sell
29
Arbutus Biopharma (ABUS)
is a Sell
Is Arbutus Biopharma a Buy, Sell or Hold?
-
The current Arbutus Biopharma [ABUS] share price is $3.32. The Score for ABUS is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
ABUS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Vista Energy SAB de CV (VIST)
is a Sell
Is Vista Energy SAB de CV a Buy, Sell or Hold?
-
The current Vista Energy SAB de CV [VIST] share price is $47.35. The Score for VIST is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
VIST is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ABUS Stock Price Chart
What is Arbutus Biopharma's stock price today?
-
The Arbutus Biopharma share price today is $3.32Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing slight selling pressure.
VIST Stock Price Chart
What is Vista Energy SAB de CV's stock price today?
-
The Vista Energy SAB de CV share price today is $47.35Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VIST is experiencing buying pressure, which is a positive indicator for future bullish movement.
ABUS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 49.64 | Sell |
| Chaikin Money Flow: | -137488 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.27 - 3.47) | Sell |
| Bollinger Bands (100): | (3.24 - 3.78) | Sell |
VIST Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.17 | Sell |
| Relative Strength Index (14 RSI): | 44.51 | Sell |
| Chaikin Money Flow: | 502084 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.02 - 53.46) | Sell |
| Bollinger Bands (100): | (48.78 - 56.34) | Sell |
ABUS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.32 | Buy |
| 20-day SMA: | 3.35 | Sell |
| 50-day SMA: | 3.33 | Sell |
| 200-day SMA: | 3.59 | Sell |
| 8-day EMA: | 3.29 | Buy |
| 20-day EMA: | 3.34 | Sell |
| 50-day EMA: | 3.38 | Sell |
| 200-day EMA: | 3.4 | Sell |
VIST Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.21 | Buy |
| 20-day SMA: | 49.52 | Sell |
| 50-day SMA: | 53.1 | Sell |
| 200-day SMA: | 49.51 | Sell |
| 8-day EMA: | 46.84 | Buy |
| 20-day EMA: | 49.01 | Sell |
| 50-day EMA: | 51.42 | Sell |
| 200-day EMA: | 48.74 | Sell |
Arbutus Biopharma Earnings Growth & ABUS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and a decrease next year of $0.08 per share.
Vista Energy SAB de CV Earnings Growth & VIST Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.75 per share, an increase next quarter of $0.11 per share, an increase this year of $0.57 per share, and an increase next year of $2.03 per share.
Arbutus Biopharma Technical Analysis
| Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | Mar | |||||||||
| 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Vista Energy SAB de CV Technical Analysis
| Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | Mar | |||||||||
| 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||